483 Hisun Pharmaceutical Hangzhou Nov 2018

483 Hisun Pharmaceutical Hangzhou Nov 2018

Christopher Middendorf FDA, Brian Ryan FDA$119.00 - Available Now

FDA investigators audited the Hisun Pharmaceutical Hangzhou - Hangzhou, China facility and issued inspectional observations (via FDA 483) on 13 Nov 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 13 Nov 2018
  • Location: Hangzhou, China
  • FEI: 3008481334
Add To Cart